Brain MRI disease burden and sex differences in cognitive performance of patients with multiple sclerosis

Jiri Motyl1, Lucie Friedova1, Ranjani Ganapathy Subramanian2

  • 1Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Multiple Sclerosis Center, Charles University and General University Hospital, Katerinska 30, 120 00, Prague, Czech Republic.

PubMed
Abstract

Insights

In multiple sclerosis (MS), men showed slightly worse verbal memory and processing speed, despite women perceiving their cognition as poorer. Brain imaging did not explain these sex differences in cognitive performance.

Area of Science:

  • Neurology
  • Neuropsychology
  • Medical Imaging

Background:

  • Cognitive deficits are common in multiple sclerosis (MS), with some evidence suggesting worse outcomes in males.
  • The influence of brain pathology on sex-based cognitive differences in MS remains underexplored.

Purpose of the Study:

  • To examine sex-based differences in cognitive performance among MS patients.
  • To investigate the relationship between brain pathology, disease burden, and cognitive function in relation to sex.

Main Methods:

  • A cohort of 1052 MS patients underwent comprehensive assessments.
  • Methods included brain Magnetic Resonance Imaging (MRI), neurological examination, neuropsychological testing (using BICAMS and PASAT), and patient-reported outcomes.

Main Results:

  • Females scored higher on the Symbol Digit Modalities Test (SDMT) and Categorical Verbal Learning Test (CVLT).
  • Paradoxically, females reported worse cognitive performance.
  • Brain MRI measures (T2 lesion volume, Brain Parenchymal Fraction) showed trends in correlation with cognitive tests, but did not significantly explain observed sex differences after statistical correction.

Conclusions:

  • While males exhibited slightly poorer verbal memory and information processing speed at a group level, the cognitive differences between sexes were less pronounced than individual score variability.
  • Brain pathology, as assessed by MRI, did not account for the observed sex differences in cognitive performance in this MS cohort.